Arcaea Acquires Gadusol Laboratories

Azelis Acquires Gillco Ingredients

May 16, 2023

Food & Beverage

Azelis has signed an agreement to acquire 100% of Gillco Ingredients, a US-based specialty ingredient provider serving the food & nutrition market. The acquisition expands Azelis' footprint in the US life sciences and food & nutrition sectors and brings Gillco's ~40 employees and application expertise into Azelis' global network.

Azelis Acquires Solchem Nature S.L. to Strengthen Nutraceutical Offering in Spain

April 7, 2025

Food & Beverage

Azelis has acquired 100% of Solchem Nature S.L., a Barcelona-based distributor of raw materials and premium ingredients for the nutraceutical and dietary supplements market. The deal expands Azelis's presence in Spain and adds Solchem's ~14-person team and network of over 250 customers to Azelis's EMEA nutraceutical platform.

Astorg to Acquire Majority Stake in Solabia Group

May 7, 2025

Biotechnology

Astorg has signed a definitive agreement to acquire a majority stake in Solabia Group from TA Associates, with TA reinvesting alongside Astorg. Solabia, a Paris-headquartered biotech ingredients manufacturer with 11 production sites, 8 R&D labs and over 900 employees, will partner with Astorg to accelerate international expansion (particularly in the US and Asia), advance product innovation and pursue targeted M&A.

Verdesian Life Sciences Acquires Cytozyme Laboratories

April 27, 2021

Agriculture

Verdesian Life Sciences has acquired Cytozyme Laboratories, Inc.; Cascadia Capital served as exclusive financial advisor to Cytozyme. The acquisition brings together complementary biological and nutritional crop technologies to expand Verdesian's product portfolio and support sustainable yield solutions for growers.

Agno Pharma Acquires Actylis Eugene (Legacy Cascade Chemistry) in Eugene, Oregon

January 15, 2026

Pharmaceuticals

Agno Pharma has acquired Actylis Eugene, the legacy Cascade Chemistry manufacturing asset in Eugene, Oregon, expanding Agno's U.S. cGMP API development and manufacturing footprint. The site includes a 16,000 sq. ft. R&D lab and a newly constructed 30,000 sq. ft. GMP manufacturing facility, enhancing Agno's capabilities to support biotech and pharmaceutical clients from early-phase through commercial API production.

Genesis Systems Acquires Molecule Inc.

May 1, 2023

Environmental Services

Genesis Systems LLC (Tampa, Florida) has acquired Molecule Inc., an emerging materials-sciences innovator, to expand its intellectual property and product portfolio for renewable water supply and utility-scale water-from-air technologies. The deal is intended to consolidate IP and technical capability to accelerate Genesis Systems' Water-as-a-Service offerings for defense, utilities and industrial end markets.